Sign Up to like & get
recommendations!
0
Published in 2024 at "Transplantation"
DOI: 10.1097/tp.0000000000005257
Abstract: Background. Peripheral blood biomarkers aim to noninvasively diagnose kidney allograft rejection, but most lack robust independent validation. TruGraf is intended to exclude subclinical cellular rejection (TCMR), whereas donor-derived cell-free DNA Viracor-TRAC has proven value in…
read more here.
Keywords:
donor derived;
trac;
rejection;
derived cell ... See more keywords